首页> 外文会议>National SBIR/STTR conference >An Enzyme-Responsive Controlled Release Drug Delivery System Based on Mesoporous Silica and DNA
【24h】

An Enzyme-Responsive Controlled Release Drug Delivery System Based on Mesoporous Silica and DNA

机译:基于介孔二氧化硅和DNA的酶反应控制释放药物递送系统

获取原文

摘要

An efficient enzyme-responsive controlled release drug delivery system was fabricated using functional mesoporous silica nanoparticles (FMSN) encapsulated with the single-stranded DNA. Based on the electrostatic interactions between FMSN and single-stranded DNA, the DNA coating could act as gates for storage of drugs. When DNase Ⅰ enzyme was added, the DNA could be hydrolyzed to plenty of tiny fragments through the hydrolysis effect of DNase Ⅰ, and obviously, the gates started to open and drugs loaded in the mesopores of MSN could be released. The system showed an excellent drug release performance, and was expected to be helpful to increase the treatment efficiency of drugs.
机译:使用与单链DNA包封的功能性介孔二氧化硅纳米粒子(FMSN)制造了一种有效的酶反应控制释放药物递送系统。基于FMSN和单链DNA之间的静电相互作用,DNA涂层可作为储存药物的栅极。当加入DNaseⅠ酶时,DNA可以通过DNaseⅠ的水解作用水解为大量的微小碎片,并且显然,开始开放的栅极和在MSN中载入的药物可以释放。该系统显示出优异的药物释放性能,预计会有助于提高药物的治疗效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号